MedTrace Logo

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life

NCT01423071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2015-06-18

No results posted yet for this study

Summary

The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in those patients with concomitant PH compared to COPD patients without PH and those only suffering from pulmonary arterial hypertension (PAH) respectively.

Conditions

  • Hypertension, Pulmonary
  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • Actelion Pharmaceuticals Deutschland GmbH

    collaborator INDUSTRY

  • Wissenschaftliches Institut Bethanien e.V

    lead OTHER

Principal Investigators

  • Winfried J Randerath, Prof. Dr. med. · Wissenschaftliches Institut Bethanien e.V

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01423071 on ClinicalTrials.gov